Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Immunicon Announces Agreements with R&D Systems

August 19th, 2003

Immunicon Announces Agreements with R&D Systems

Abstract:
Immunicon Corporation today announced the completion of a non-exclusive license and supply agreement with R&D Systems, Inc. of Minneapolis, MN. In addition, under the terms of a separate agreement, R&D Systems, a wholly-owned subsidiary of Techne Corporation made an equity investment in Immunicon. Under the license and supply agreement, R&D Systems will use Immunicon's magnetic nano-particle cell isolation technology in conjunction with their reagents to develop products for life science research. (PDF)

Source:
PRNewswire

Bookmark:

Related News Press

Nanomedicine

Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013

Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013

Pitt Chemists Demonstrate Nanoscale Alloys So Bright They Could Have Potential Medical Applications: “Think about a particle that will not only help researchers detect cancer sooner but be used to treat the tumor, too.” May 15th, 2013

Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013